作者： sarah

TOKYO, Nov 18, 2024 - (JCN Newswire via SeaPRwire.com) - NEC Corporation (NEC; TSE: 6701) today announced a successful trial of tokens(1) created using quantum technology (quantum tokens) in cooperation with Tokyo-based Mitsui & Co., Ltd. (Mitsui) and U.S.-based Quantinuum.Mitsui and Quantinuum, which is engaged in the global rollout of quantum computing, have been working to develop practical unforgeable quantum tokens based on properties of quantum physics that are patented by Quantinuum. Until now, the principle behind quantum tokens had been proven in theory, but this time, using a quantum key distribution (QKD)(2) system for quantum cryptography communications(3) provided by NEC and 10km of optical fiber cable, the world's first demonstration experiment has been conducted to issue and redeem quantum tokens in an environment assumed for commercial use, and it was confirmed that tokens can be issued and redeemed as theoretically predicted.Unlike the tokens used in conventional communications technology, quantum tokens cannot be forged and can be redeemed instantly. Thanks to these characteristics, it will be possible to use them for a variety of purposes, including data restoration and certification, primarily for financial sector applications, such as high-speed transactions and commodity trading. The quantum cryptographic communication technology used in the trial is expected to be used in future infrastructure development as a communication method that cannot be decrypted by quantum computers, and quantum tokens can be used on this infrastructure. Based on the results of this trial, NEC will continue to work towards the social implementation of quantum cryptography technology.The equipment provided by NEC was partially supported by "Research and Development for the Construction of a Global Quantum Cryptographic Communication Network (JPJ008957)" project, which is part of the results from Japan’s Ministry of Internal Affairs and Communications’ (MIC) "R&D of ICT Priority Technology Project" (JPMI00316) and Japan’s Cabinet Office’s "Photonics and Quantum Technology for Society 5.0" project under the Cross-ministerial Strategic Innovation Promotion Program (SIP).(1) Token: A digital certificate indicating certain rights and values, such as digital assets, user information, and access rights.(2) Quantum key distribution (QKD) systems use quantum mechanics to share random secret keys between two communicating parties in order to guarantee secure communication, and then encrypt and decrypt information based on those keys. (Patented (as of November 18, 2024))(3 )Quantum cryptographic communication: Various companies are working to develop communications technologies that employ quantum properties to make eavesdropping physically impossible. In order to achieve this, quantum cryptographic communication uses encryption based on quantum properties.ShareAbout NEC CorporationNEC Corporation has established itself as a leader in the integration of IT and network technologies while promoting the brand statement of “Orchestrating a brighter world.” NEC enables businesses and communities to adapt to rapid changes taking place in both society and the market as it provides for the social values of safety, security, fairness and efficiency to promote a more sustainable world where everyone has the chance to reach their full potential. For more information, visit NEC at https://www.nec.com. Copyright 2024 JCN Newswire via SeaPRwire.com.

Kawasaki, Japan and Walldorf, German, Nov 18, 2024 - (JCN Newswire via SeaPRwire.com) - Fujitsu and SAP Fioneer have signed a partnership master agreement to accelerate the digital transformation of Japan’s insurance industry. Under the agreement, Fujitsu and SAP Fioneer will collaborate on product planning, development, and marketing, including the development of the Japan Edition of SAP Fioneer Cloud for Insurance (1), an end-to-end cloud-based platform that packages core insurance services and combines localized business content with global industry best practice.The insurance industry is undergoing a profound transformation driven by technological advancements, including the rise of the digital native generation and the emergence of FinTech companies, but also societal challenges including declining birth rates and an aging population. These dynamics are not only reshaping customer expectations but also intensifying the competitive landscape – both on a global scale and in Japan. To ensure that they are positioned for sustainable success in a rapidly evolving market, insurers need to address critical challenges such as outdated and opaque legacy systems and a shortage of skilled IT professionals, and accelerate digital transformation to enhance compliance and operational efficiency.With the Japan Edition of SAP Fioneer Cloud for Insurance that Fujitsu plans to provide, customers will be able to quickly standardize core insurance operations and systems such as product management, quotation and underwriting management, policy management and claim management. They will also gain a competitive advantage by strategically allocating resources, such as personnel and investments, to high value-added areas such as new product development and sales channel expansion, while ensuring robust IT capabilities and continuous quality improvements.In addition, by developing this edition as the de facto standard for business collaboration in the insurance industry in Japan, Fujitsu and SAP Fioneer aim to drive innovation in products, channels and processes, as well as strengthen governance across the sector.Based on this partnership agreement, Fujitsu will conduct proof-of-concept projects with customers to validate the feasibility of the Japan Edition of SAP Fioneer Cloud for Insurance and aims to start offering the service by the end of March 2026.Masaru Yagi, Corporate Executive Officer, EVP, Vice Head of Global Customer Success, Fujitsu Limited, comments:“We are excited to start a partnership with SAP Fioneer. The collaboration marks a pivotal moment in our efforts to drive digital transformation (DX) for our financial customers. By merging SAP Fioneer's cutting-edge financial services solutions with Fujitsu's unparalleled expertise and quality in system development for the financial sector, we are poised to deliver groundbreaking and efficient solutions like never before. Through this partnership, we will closely collaborate with SAP Fioneer from product planning to development and marketing, and advance DX in the financial industry.”Chirag Shah, Managing Director Insurance, SAP Fioneer comments:“Japan's insurance market requires solutions that address its unique local regulatory and functional requirements. In response to the industry's demand for an adaptable packaged software suited to the Japanese insurance sector, we are partnering with Fujitsu to develop the Japan Edition of SAP Fioneer Cloud for Insurance, our core insurance platform, which combines localized business content with global industry best practices.”(1) Cloud for Insurance: SAP Fioneer solution that covers end-to-end core insurance business processes, including product management, quoting and underwriting, contract management, insurance payments, and claims collection. It is built on SAP Fioneer’s proven and performant technology and is trusted by major insurers around the world.About FujitsuFujitsu’s purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers in over 100 countries, our 124,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: Computing, Networks, AI, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.7 trillion yen (US$26 billion) for the fiscal year ended March 31, 2024 and remains the top digital services company in Japan by market share. Find out more: www.fujitsu.com.About SAP FioneerSAP Fioneer was launched in 2021 as a joint venture between global technology leader SAP and entrepreneurial investor Dediq to become the world’s leading provider of financial services software solutions and platforms.With a broad ecosystem of partners, over 800 financial services customers and more than 1,300 employees, SAP Fioneer is a global business present in 17 countries across Europe, North and Latin America, Middle East and Asia-Pacific.Press Contacts:Fujitsu LimitedPublic and Investor Relations DivisionInquiriesSAP FioneerContact, press only:E-mail: press@sapfioneer.com Copyright 2024 JCN Newswire via SeaPRwire.com.

Toyota City, Japan, Nov 18, 2024 - (JCN Newswire via SeaPRwire.com) - Toyota Motor Corporation (Toyota) will enter the ENEOS Super Taikyu Series 2024 Empowered by BRIDGESTONE Round 7 Super Taikyu Final Fuji, to be held from November 16 to 17, with the #32 ORC ROOKIE GR Corolla H2 Concept, a hydrogen-powered GR Corolla running on liquid hydrogen.Liquid hydrogen-powered GR CorollaToyota will also be exhibiting a concept model that envisions the use of boil-off gas* generated while driving as it looks for partners to take on the challenge of developing the technology together.*Boil-off gas Hydrogen that vaporizes from liquid hydrogen fuel stored in the tank due to natural heat that enters from outside.Forming partnerships to take on the challenge of using boil-off gas generated while drivingLiquid hydrogen has a higher density than gaseous hydrogen. This allows for more hydrogen to be stored in a tank of the same capacity but presents an issue of boil-off. This is a problem for all liquid hydrogen systems, where the liquid hydrogen fuel stored in the tank evaporates due to natural heat that enters from outside. Until now, the boil-off gas (vaporized hydrogen) generated in the fuel tank while driving has been released into the atmosphere without being used.At the Super Taikyu Final Fuji, Toyota will exhibit a new concept model that utilizes the boil-off gas. Although it is still in the concept stage, if realized, this technology is expected to improve the energy efficiency of the entire liquid hydrogen system by recovering and using boil-off gas as energy. Thus, Toyota is looking to form partnerships that will help make this technology a reality.Overall image of boil-off gas utilization1. Reusing boil-off gas as fuelToyota is working on the development of technology to produce reusable fuel by sending boil-off gas released from liquid hydrogen in the tank to a self-pressurizer (a device that increases pressure without relying on external energy). Boil-off gas can be converted back to usable hydrogen fuel for the engine by applying pressure, but increasing the pressure sufficiently usually requires energy such as electricity. The self-pressurizer that will be exhibited at this event uses the pressure of the boil-off gas to increase pressure by two to four times and produce reusable fuel without using any additional energy.Self-pressurizer for increasing the pressure of boil-off gas (The meter on the left displays pressure after the increase, and the meter on the right displays pressure before the increase.)2. Generating electricity using boil-off gasDuring the pressurization process for reusing boil-off gas (vaporized hydrogen), as in (1), a certain amount of surplus boil-off gas is still released.This is then fed into the small fuel cell package (FC stack) that Toyota has developed, and the hydrogen goes through a chemical reaction to generate electricity. The electricity generated can be used to power parts like the motor for the liquid hydrogen pump. If realized, it will be possible to supplement electricity equivalent to the amount generated by the alternator (small generator) from boil-off gas, leading to an improvement in energy efficiency.Small FC stack that generates electricity using boil-off gas3. Safely releasing surplus boil-off gas through catalystBoil-off gas that is not used in the electricity generation process in (2) is then converted into water vapor through a catalyst as before and safely released outside the vehicle.Catalyst to treat surplus boil-off gasToyota will continue to refine cars and people in the challenging world of motorsports and evolve together with its partners to achieve carbon neutrality.About Toyota

Toyota strives to be a strong corporate citizen, engaging with and earning the trust of its stakeholders, and to contribute to the creation of a prosperous society through all its business operations.Our corporate principles form the basis of our initiatives, reflect values that enable action, and drive our mindset.For the latest Toyota-related news and information:https://tinyurl.com/ToyotaPressReleasenewsroom@global.toyota Copyright 2024 JCN Newswire via SeaPRwire.com.

SAN FRANCISCO, CA & MUMBAI, Nov 18, 2024 - (ACN Newswire via SeaPRwire.com) - CleverTap, the all-in-one engagement platform has been recognized as a ‘Strong Performer’ in The Forrester Wave™: Cross-Channel Marketing Hubs, Q4 2024. The report evaluated 14 top global vendors across 28 criteria, including experience optimization, identity resolution and privacy, customer analytics, and mobile.CleverTap received its highest scores in three key evaluation criteria – Experience optimization, mobile, and pricing flexibility and transparency. Moreover, CleverTap is also among the only three vendors, out of the top 14 global providers evaluated, to receive ‘above average’ customer feedback, which, we believe is a testament to the positive feedback from CleverTap customers, signifying trust and loyalty with the brand.Anand Jain, Co-founder and Chief Product Officer, CleverTap said, “At CleverTap, our focus has always been on empowering brands to deliver personalized experiences that resonate deeply with their audiences. And we believe that being recognized as a Strong Performer in the Forrester Wave™ CCMH Hubs 2024 report not only validates our commitment but also strengthens our resolve to continue setting new standards in customer engagement and growth."The Forrester Wave™ Cross Channel Marketing Hubs, Q4 2024 report states that “CleverTap offers an all-in-one platform for midsize enterprises; larger enterprises should consider its verticalized solutions to complement their Cross-Channel Marketing Hub (CCMH) ecosystem.” Customers trust CleverTap; one noted how it understands their tech needs to integrate across marketing, CRM, and operations. The company’s vision for inconspicuous engagement, based on customer consent and anticipation – resonates well, as does its view that MarTech should be a living cartography or ecosystem rather than a fixed stack. Additionally, IntelliNODE stands out as an embedded AI copilot that creates a network of experiments and automatically determines winning engagement paths, balancing individual and broader segment optimization.For more insights, you can access your complimentary copy of the report here:https://clevertap.com/forrester-wave-cross-channel-marketing-hubs-q4-2024-report/ About CleverTapCleverTap is the leading all-in-one customer engagement platform that helps brands unlock limitless customer lifetime value. CleverTap is trusted by over 2000 brands like Decathlon, Domino’s, Levis, Jio, Emirates NBD, Puma, Croma (A Tata Enterprise), Swiggy, SonyLIV, Axis Bank, AirAsia, TD Bank, Ooredoo, and Tesco to help build personalized experiences for all their customers. The platform is powered by TesseractDB™ – the world’s first purpose-built database for customer engagement, offering speed and cost efficiency at scale.Backed by top-tier investors such as Accel, Peak XV Partners, Tiger Global, CDPQ and 360 One, the company is headquartered in San Francisco, with presence across Seattle, London, São Paulo, Bogota, Mexico, Amsterdam, Sofia, Dubai, Mumbai, Bangalore, Singapore, Vietnam, and Jakarta. For more information, visit clevertap.com or follow us on:LinkedIn: https://www.linkedin.com/company/clevertap/ X: https://twitter.com/CleverTap Forward-Looking StatementsSome of the statements in this press release may represent CleverTap's belief in connection with future events and may be forward-looking statements, or statements of future expectations based on currently available information. CleverTap cautions that such statements are naturally subject to risks and uncertainties that could result in the actual outcome being absolutely different from the results anticipated by the statements mentioned in the press release.Factors such as the development of general economic conditions affecting our business, future market conditions, our ability to maintain cost advantages, uncertainty with respect to earnings, corporate actions, client concentration, reduced demand, liability or damages in our service contracts, unusual catastrophic loss events, war, political instability, changes in government policies or laws, legal restrictions impacting our business, impact of pandemic, epidemic, any natural calamity and other factors that are naturally beyond our control, changes in the capital markets and other circumstances may cause the actual events or results to be materially different, from those anticipated by such statements. CleverTap does not make any representation or warranty, express or implied, as to the accuracy, completeness, or updated or revised status of such statements. Therefore, in no case whatsoever will CleverTap and its affiliate companies be liable to anyone for any decision made or action taken in conjunction.For more information:SONY SHETTYDirector, Communications, CleverTap+91 9820900036sony@clevertap.com ASHMIT CHAUDHARYAssociate Consultant, Archetype+91 8850752121ashmit.chaudhary@archetype.co Copyright 2024 JCN Newswire via SeaPRwire.com.

TOKYO, Nov 15, 2024 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Shipbuilding Co., Ltd., a Mitsubishi Heavy Industries (MHI) Group company, today held a christening and launch ceremony for the TRANS HARMONY EMERALD, the second of two LNG-powered roll-on/roll-off (RO/RO) ships(Note) under construction for Toyofuji Shipping Co., Ltd. The ceremony took place at the Enoura Plant of MHI's Shimonoseki Shipyard & Machinery Works in Yamaguchi Prefecture. The ship's handover is scheduled for June 2025 following completion of outfitting work and sea trials. The TRANS HARMONY EMERALD will serve as a RO/RO vessel on shipping routes in Asia.Christening and Launch Ceremony of TRANS HARMONY EMERALDThe TRANS HARMONY EMERALD is approximately 195 meters in overall length, approximately 30.6 meters in breadth, and has gross tonnage of approximately 49,500. It can simultaneously transport about 3,000 passenger cars. The ship's main engine and main generator engine are high-performance dual-fuel engines each accommodating LNG or diesel fuel. Together these engines enable a greater than 25% reduction in CO2 emissions compared to ships with the same hull and powered by fuel oil, cutting SOx (sulfur oxides) emissions to near zero, thereby helping to reduce the vessel's environmental footprint.The christening and launch ceremony of the first vessel, "TRANS HARMONY GREEN," for Toyofuji Shipping, has already been held this June, and its handover is scheduled for late January 2025.Mitsubishi Shipbuilding, as part of MHI Group's strategic initiatives for energy transition, today contributes toward realizing a carbon-neutral world by building LNG-powered ships enabling the maritime industry to achieve a low-carbon footprint. Going forward, as a maritime system integrator the Company will continue to work with its business partners to solve diverse issues through construction of ferries and RO/RO ships that will contribute to stable operations at sea while also providing outstanding energy and environmental performance.RO/RO ships are equipped with a ferry-type ramp enabling direct vehicle access, including cargo-loaded trucks and trailers.About MHI GroupMitsubishi Heavy Industries (MHI) Group is one of the world’s leading industrial groups, spanning energy, smart infrastructure, industrial machinery, aerospace and defense. MHI Group combines cutting-edge technology with deep experience to deliver innovative, integrated solutions that help to realize a carbon neutral world, improve the quality of life and ensure a safer world. For more information, please visit www.mhi.com or follow our insights and stories on spectra.mhi.com. Copyright 2024 JCN Newswire via SeaPRwire.com.

TOKYO, Nov 15, 2024 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. and Biogen Japan Ltd announced today that a TV commercial will be broadcast nationwide in Japan from November 15 with the aim of increasing public understanding of MCI (Mild Cognitive Impairment).MCI refers to the stage between "normal brain function" and "dementia," where the individual can still lead an independent daily life but cognitive functions of the brain, such as memory and judgment, have somewhat declined. If cognitive function further declines from the MCI stage to a state where it disrupts daily life and care becomes necessary, it is then diagnosed as dementia.In 2022, there were 5.58 million people living with MCI in Japan, accounting for 15.5% of those aged 65 and over, and estimated to reach 6.12 million by 2040. 1 While MCI is often referred to as a precursor to dementia, it doesn’t necessarily progress to dementia. Depending on the cause, the condition may be maintained, or even improved. If you are concerned about forgetfulness, early consultation with a specialist is important for the early detection of MCI and clarification of its cause, through which appropriate measures can be taken to prevent the progression from MCI to dementia.  This TV commercial tells the story of a mother whose daughter worries for her, always telling her "You just said that earlier". The mother realizes that the forgetfulness she attributed to old age might in fact be due to MCI, leading her to seek medical advice.A survey2 conducted by Eisai showed that awareness of the term "MCI" was 12%, while understanding of it was only 2%, which is still low. Through this TV commercial, Eisai and Biogen Japan hope to increase awareness of MCI among a broader range of people, thereby raising public interest in cognitive impairment and contributing to the early detection and treatment of MCI.(1) Research on the Prevalence and Future Projections of Dementia and Mild Cognitive Impairment, 2023 Elderly Health  Promotion Project Grant, Professor Toshiharu Ninomiya, Kyushu University(2) Internet surveyTarget: Japan nationwide, men and women aged 60-70, 2000 responsesSurvey period: February 2024Survey conducted by: Macromill Carenet, Inc.   About the TV CommercialTitle: MCI Disease Awareness TV Commercial "Don't Miss it, MCI" Edition (15 seconds/30 seconds)TV Broadcast Start: November 15, 2024Broadcasting Area: Japan nationwideMain CM Video: Published on YouTube from November 15(https://youtube.com/@patients_eisai?si=vLaA-y07QAlORHLa)About EisaiEisai's Corporate Concept is "to give first thought to patients and people in the daily living domain, and to increase the benefits that health care provides." Under this Concept (also known as human health care (hhc) Concept), we aim to effectively achieve social good in the form of relieving anxiety over health and reducing health disparities. With a global network of R&D facilities, manufacturing sites and marketing subsidiaries, we strive to create and deliver innovative products to target diseases with high unmet medical needs, with a particular focus in our strategic areas of Neurology, Oncology and Global Health.Theoria technologies Co., Ltd., a member of the Eisai Group, operates the dementia portal site "Theotol" (https://theotol.soudan-e65.com/), which provides easy-to-understand contents and services for the general public about MCI and various types of dementia, their causes, treatments, as well as caregiving methods and personal experiences. (Japanese only)About Biogen JapanFounded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth.We routinely post information on Biogen Japan that may be important to investors on our website at https://www.biogen.com/ and social media X, LinkedIn, Facebook, YouTubeMEDIA CONTACTSEisai Co., Ltd.Public Relations DepartmentTEL：+81 (0)3-3817-5120Biogen Japan, Ltd.Corporate AffairsTEL：＋81-70-1501-4315E-mail: Japan-PA@biogen.com Copyright 2024 JCN Newswire via SeaPRwire.com.

TOKYO, Nov 15, 2024 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. and Biogen Inc. announced today a positive opinion has been received from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommending approval of the amyloid-beta (Aβ) monoclonal antibody lecanemab as a treatment of adult patients with a clinical diagnosis ofmild cognitive impairment and mild dementia due to Alzheimer’s disease (Early Alzheimer’s disease) who are apolipoprotein E ε4 (ApoE ε4)* non-carriers or heterozygotes with confirmed amyloid pathology.1 Eisai had requested a re- examination of the prior negative opinion adopted by the CHMP in July 2024. In accordance with European Medicines Agency regulatory process,the European Commission is expected to make a final decision on the marketing authorization application (MAA) of lecanemab based on the CHMP recommendation within 67 days of receipt of CHMP opinion.2Lecanemab selectively binds to soluble Aβ aggregates (protofibrils**), as well as insoluble Aβ aggregates (fibrils) which are a major component of Aβ plaques in AD, thereby reducing both Aβ protofibrils and Aβ plaques in the brain.3,4,5AD currently affects an estimated 6.9 million people in Europe,6 and this figure is expected to nearly double by 2050 as agingpopulations increase.7 AD progresses in stages that increase in severity over time, and each stage of the disease presentsdifferent challenges for those living with AD and their care partners. There is a significant unmet need for new treatment options that slow down the progression of early AD and reduce the overall burden on people affected by AD and society.Eisai serves as the lead for lecanemab’s development and regulatory submissions globally with both Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision- making authority.* Apolipoprotein E is a protein involved in the metabolism of fats in humans. It is implicated in AD.** Protofibrils are believed to contribute to the brain injury that occurs with AD and are considered to be the most toxic form of Aβ, having a primary role in the cognitive decline of this progressive, debilitating condition.8 Protofibrils cause injury to neurons in the brain which, in turn,can negatively impact cognitive function via multiple mechanisms,8 not only increasing the development of insoluble Aβ plaques but also increasing direct damage to brain cell membranes and the connections that transmit signals between nerve cells or nerve cells and other cells. It is believed the reduction of protofibrils may slow the progression of AD by reducing damage to neurons in the brain and cognitive dysfunction.9About lecanemab (generic name, brand name: Leqembi®)Lecanemab is the result of a strategic research alliance between Eisai and BioArctic. It is a humanized immunoglobulin gamma 1 (IgG1) monoclonal antibody directed against aggregated soluble (protofibril) and insoluble forms of amyloid-beta (Aβ).Lecanemab’s Positive Opinion from the CHMP in the European Union was primarily based on Phase 3 data from Eisai’sglobal Clarity AD clinical trial, in which it met its primary endpoint and all key secondary endpoints with statistically significant results.1,3 Clarity AD was a Phase 3 global, placebo-controlled, double-blind, parallel-group, randomized study in1,795 patients with early AD (MCI or mild dementia due to AD, with confirmed presence of amyloid pathology), of which 1,521 were in the recommended indicated population (ApoE ε4 non-carriers or heterozygotes ). The treatment group was administered lecanemab 10 mg/kg bi-weekly, with participants allocated in a 1:1 ratio to receive either placebo or lecanemab for 18 months.1The primary endpoint was the global cognitive and functional scale, CDR-SB.1 In the Clarity AD clinical trial, treatment with lecanemab, in the recommended indicated population (ApoE ε4 non- carriers or heterozygotes), reduced clinical decline onCDR-SB by 31% at 18 months compared to placebo based on conservative control based imputation.1 The mean CDR-SB score at baseline was approximately 3.2 in both groups.1 The adjusted least-squares mean change from baseline at 18months was 1.217 with lecanemab and 1.752 with placebo (difference, −0.535; 95% confidence interval [CI], −0.778 to−0.293; P=0.00001).1 CDR-SB is a global cognitive and functional scale that measures six domains of functioning, including memory, orientation, judgement and problem solving, community affairs, home and hobbies, and personal care.10In addition, the secondary endpoint from the AD Cooperative Study-Activities of Daily Living Scale for Mild Cognitive Impairment (ADCS-MCI-ADL), which measures information provided by people caring for patients with AD, noted 33% less decline compared to placebo at 18 months.1 The adjusted mean change from baseline at 18 months in the ADCS-MCI-ADLscore was −3.873 in the lecanemab group and −5.809 in the placebo group (difference, 1.936; 95% CI, 1.029 to 2.844; P=0.00002).1 The ADCS-MCI-ADL assesses the ability of patients to function independently, including being able to dress, feed themselves and participate in community activities.In the ApoE ε4 heterozygotes or non-carriers population, the most common adverse reactions were infusion-related reaction (26%), ARIA-H (13%), headache (11%) and ARIA-E (9%).1Lecanemab has been approved in the U.S., Japan, China, South Korea, Hong Kong, Israel, the United Arab Emirates and Great Britain and is under regulatory review in 17 countries. A supplemental Biologics License Application (sBLA) for intravenous maintenance dosing was submitted to the U.S. Food and Drug Administration (FDA) in March 2024, which was accepted in June 2024. In May 2024, the rolling submission of a Biologics License Application (BLA) for maintenancedosing of a subcutaneous injection formulation, which is being developed to enhance convenience for patients, was initiated in the U.S. under Fast Track status, with the rolling submission and completed in October 2024.Since July 2020 the Phase 3 clinical study (AHEAD 3-45) for individuals with preclinical AD, meaning they are clinically normal and have intermediate or elevated levels of amyloid in their brains, is ongoing. AHEAD 3-45 is conducted as a public-private partnership between the Alzheimer's Clinical Trial Consortium that provides the infrastructure for academic clinical trials in AD and related dementias in the U.S, funded by the National Institute on Aging, part of the National Institutes of Health, Eisai and Biogen. Since January 2022, the Tau NexGen clinical study for Dominantly Inherited AD (DIAD), that is conducted by Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU), led by Washington University School ofMedicine in St. Louis, is ongoing and includes lecanemab as the backbone anti-amyloid therapy.About the Collaboration between Eisai and Biogen for ADEisai and Biogen have been collaborating on the joint development and commercialization of AD treatments since 2014. Eisai serves as the lead of lecanemab development and regulatory submissions globally with both companies co-commercializing and co-promoting the product and Eisai having final decision-making authority.About the Collaboration between Eisai and BioArctic for ADSince 2005, Eisai and BioArctic have had a long-term collaboration regarding the development and commercialization of ADtreatments. Eisai obtained the global rights to study, develop, manufacture and market lecanemab for the treatment of AD pursuant to an agreement with BioArctic in December 2007. The development and commercialization agreement on the antibody lecanemab back-up was signed in May 2015.About Eisai Co., Ltd.Eisai's Corporate Concept is "to give first thought to patients and people in the daily living domain, and to increase thebenefits that health care provides." Under this Concept (also known as human health care (hhc) Concept), we aim toeffectively achieve social good in the form of relieving anxiety over health and reducing health disparities. With a global network of R&D facilities, manufacturing sites and marketing subsidiaries, we strive to create and deliver innovative products to target diseases with high unmet medical needs, with a particular focus in our strategic areas of Neurology and Oncology.In addition, we demonstrate our commitment to the elimination of neglected tropical diseases (NTDs), which is a target (3.3) of the United Nations Sustainable Development Goals (SDGs), by working on various activities together with global partners.For more information about Eisai, please visit www.eisai.com (for global headquarters: Eisai Co., Ltd.), and connect with us on X, LinkedIn and Facebook. The website and social media channels are intended for audiences outside of the UK and Europe. For audiences based in the UK and Europe, please visit www.eisai.eu and Eisai EMEA LinkedIn.About BiogenFounded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patient’s lives and to create value for shareholders and our communities. We apply deep understanding ofhuman biology and leverage different modalities to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth.The company routinely posts information that may be important to investors on its website at www.biogen.com.Follow Biogen on social media – Facebook, LinkedIn, X, YouTube.Biogen Safe HarborThis news release contains forward-looking statements, including about the potential clinical effects of lecanemab; the potential benefits, safety and efficacy of lecanemab; potential regulatory discussions, submissions and approvals and the timing thereof; the treatment of Alzheimer's disease; the anticipated benefits and potential of Biogen's collaboration arrangements with Eisai; the potential of Biogen's commercial business and pipeline programs, including lecanemab; and risks and uncertainties associated with drug development and commercialization. These statements may be identified by words such as "aim," "anticipate," "believe," "could," "estimate," "expect," "forecast," "intend," "may," "plan," "possible," "potential," "will," "would" and other words and terms of similar meaning. Drug development and commercialization involve a high degree of risk, and only a small number of research and development programs result in commercialization of a product. Results in early-stage clinical studies may not be indicative of full results or results from later stage or larger scale clinical studies and do not ensure regulatory approval. You should not place undue reliance on these statements.These statements involve risks and uncertainties that could cause actual results to differ materially from those reflected insuch statements, including without limitation unexpected concerns that may arise from additional data, analysis or results obtained during clinical studies; the occurrence of adverse safety events; risks of unexpected costs or delays; the risk of other unexpected hurdles; regulatory submissions may take longer or be more difficult to complete than expected;regulatory authorities may require additional information or further studies, or may fail or refuse to approve or may delayapproval of Biogen's drug candidates, including lecanemab; actual timing and content of submissions to and decisions madeby the regulatory authorities regarding lecanemab; uncertainty of success in the development and potentialcommercialization of lecanemab; failure to protect and enforce Biogen's data, intellectual property and other proprietaryrights and uncertainties relating to intellectual property claims and challenges; product liability claims; and third party collaboration risks, results of operations and financial condition. The foregoing sets forth many, but not all, of the factors that could cause actual results to differ from Biogen's expectations in any forward-looking statement. Investors should considerthis cautionary statement as well as the risk factors identified in Biogen's most recent annual or quarterly report and in otherreports Biogen has filed with the U.S. Securities and Exchange Commission. These statements speak only as of the date of this news release. Biogen does not undertake any obligation to publicly update any forward-looking statements.References:1) Committee for Medicinal Products for Human Use. 2024. Leqembi (Lecanemab). Overview. Last accessed: November 2024(2) European Medicines Agency. The Centralised Procedure at the EMA. Available at: https://www.ema.europa.eu/en/about-us/what-we-do/authorisation-medicines. Last accessed: November 2024.(3) van Dyck, H., et al. Lecanemab in Early Alzheimer’s Disease. New England Journal of Medicine. 2023;388:9-21. https://www.nejm.org/doi/full/10.1056/NEJMoa2212948.(4) AlzForum. 2021. Lecanemab Sweeps Up Toxic Aβ Protofibrils, Catches Eyes of Trialists. Available at: https://www.alzforum.org/news/conference-coverage/lecanemab-sweeps-toxic-av-protofibrils- catches-eyes-trialists. Last accessed: February 2024.(5) Sehlin D, Englund H, Simu B, Karlsson M, Ingelsson M, Nikolajeff F, Lannfelt L, Pettersson FE. Large aggregates are the major soluble Aβ species in AD brain fractionated with density gradient ultracentrifugation. PLoS One. 2012;7(2):e32014.https://doi.org/10.1371/journal.pone.0032014 Epub 2012 Feb 15. PMID: 22355408; PMCID: PMC3280222.(6) Gustavsson, A., et al. Global estimates on the number of persons across the Alzheimer's disease continuum. Alzheimer’s & Dementia. 2023;19:658-670. https://alz- journals.onlinelibrary.wiley.com/doi/full/10.1002/alz.12694.(7) Alzheimer Europe. Prevalence of dementia in Europe. Available at: https://www.alzheimer-europe.org/dementia/prevalence-dementia-europe.(8) Amin L, Harris DA. Aβ receptors specifically recognize molecular features displayed by fibril ends and neurotoxic oligomers. Nat Commun. 2021;12:3451. doi:10.1038/s41467-021-23507-z(9) Ono K, Tsuji M. Protofibrils of Amyloid-β are Important Targets of a Disease-Modifying Approach for Alzheimer's Disease. Int J Mol Sci. 2020;21(3):952. doi: 10.3390/ijms21030952. PMID: 32023927; PMCID: PMC7037706.(10) Morris, J.C. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43:2412-2414.MEDIA CONTACTSEisai Co., Ltd.Public Relations Department TEL: +81 (0)3-3817-5120Eisai Europe, Ltd.EMEA Communications Department+44 (0) 797 487 9419Emea-comms@eisai.netBiogen Inc.Jack Cox+ 1-781-464-3260public.affairs@biogen.comEisai Inc. (U.S.)Libby Holman+1-201-753-1945Libby_Holman@Eisai.comINVESTOR CONTACTSEisai Co., Ltd.Investor Relations Department TEL: +81 (0) 3-3817-5122Biogen Inc.Stephen Amato+ 1-781-464-2442IR@biogen.com Copyright 2024 JCN Newswire via SeaPRwire.com.

TOKYO, Nov 15, 2024 - (JCN Newswire via SeaPRwire.com) - Resorttrust Group and Mitsubishi Corporation ("MC") have agreed to conduct a joint study of opportunities in the medical tourism sector. Under this agreement, MC and Resorttrust Group company Advanced medical care Inc.("AMC") will evaluate the establishment of a joint venture company to facilitate medical tourism to Japan and globally promote the country's advanced medical screening technologies and healthcare services.Rapid population growth and economic development in Asia have raised awareness of lifestyle-related diseases and preventive healthcare, which has in turn driven up demand for high-precision medical screenings and treatments. Resorttrust Group and MC aim to capitalizing on this growing demand by promoting medical tourism to Japan, which is renowned for its abundant medical facilities, advanced screening technologies, and high-quality healthcare services. Our objectives are to help extend worldwide healthy life expectancy and create new economic value by leveraging both the growth of Japan's healthcare-related industries and the revitalization of its local economies.In addition to providing administrative support for its Group's medical facilities, Resorttrust's know-how extends to healthcare technologies and services, as well as hotel and other tourism operations. MC brings to the table a global network of business partners, digital-transformation (DX) capabilities, and solutions for healthcare providers. This new joint venture will combine our companies' respective expertise to accomplish the following aims:1. Strengthen overseas marketing of Japanese medical services2. Develop inbound patient referral schemes for domestic medical institutions3. Take advantage of medical-facility DX to accelerate the establishment of inbound patient acceptance systemsMC and Resorttrust Group are confident that success in these initiatives will encourage global applications of Japan's medical services. Looking further to the future, our goal is to develop businesses that are invested in the mental and physical well-being of people all over the world, including wellness-tourism services that deliver Japanese health culture and traditional culture experiences.As part of this joint study, we will conduct the following verification activities at several facilities, including Nihonbashi Muromachi Mitsui Tower Midtown Clinic and Tokyo Tower Midtown Clinic, which are operated by AMC:- Market research in Asian countries for the global expansion of Japanese medical screening technologies and healthcare services- Analysis of current challenges and enhancement measures related to inbound patient referral processes- Effectiveness evaluation of AI-powered multilingual communication tools specialized for medical services, developed in collaboration with the MC Group companies, Industry One, Inc. and MC Digital, Inc.About Resorttrust, Inc.Resorttrust Group's core business includes membership-based resort hotels and hotel restaurant operations. In 1994, the group expanded into the medical /healthcare sector by launching a membership-based comprehensive medical club. Today, the group has broadened its healthcare solutions beyond medical screenings into treatment services. The group's subsidiary, Cancer Intelligence Care Systems, Inc., is developing an accelerator-based neutron irradiation system for Boron Neutron Capture Therapy, aiming to provide cancer treatments with reduced patient burden. Additionally, Resorttrust Group provides operational support to facilities offering advanced cancer immunotherapy and stem cell treatments for conditions such as arteriosclerosis, joint pain, and frailty prevention and improvement. https://www.resorttrust.co.jp/About Advanced Medical Care Inc.Consulting for medical and health screening business, support for medical facility management, education and training of medical personnel and assistants, sales of cosmetics and supplements. https://www.amcare.co.jp/About Mitsubishi CorporationMC develops diversified businesses in a wide range of industries through its eight groups: Environmental Energy, Materials Solution, Mineral Resources, Urban Development & Infrastructure, Mobility, Food Industry, S.L.C. (Smart-Life Creation), and Power Solution. https://www.mitsubishicorp.com/  Copyright 2024 JCN Newswire via SeaPRwire.com.

News Facts:Collaboration with 12 global suppliers to calculate and exchange CO2 emissions data, using a PACT -conformant solution with global standardsFujitsu's innovative offering enables transparent and reliable data exchange for calculating product carbon footprints at both product and organizational levels, allowing for visualization and reduction of emissions across the entire supply chainInitiative conformance to global standards, including the PACT Methodology, and demonstrates interoperability with solutions from multiple international partners, showcasing Fujitsu's commitment to achieving net-zero emissions across value chains by 2040KAWASAKI, Japan, Nov 15, 2024 - (JCN Newswire via SeaPRwire.com) - Fujitsu today announced that it has started an initiative on decarbonization with global suppliers leveraging product-level data exchange on CO2 emissions. The initiative represents part of Fujitsu’s efforts to achieve net zero CO2 emissions (1) across its entire value chain (Scope 3) by 2040.To achieve these decarbonization goals, since fiscal 2024, Fujitsu has been deepening its engagement with suppliers, implementing data exchange between companies using product carbon footprint (PCFs) with actual data to visualize and reduce CO2 emissions from purchased parts and materials.The initiative leverages Fujitsu's ESG Management Platform, a solution that supports the realization of corporate ESG management by visualizing, measuring, and optimizing CO2 emission reductions. Fujitsu is working with a total of 12 global suppliers (2), including Accton Technology Corporation, KAGA FEI Co., Ltd., NEXTY Electronics Corporation, Schneider Electric, Hakuto Co., Ltd., Furukawa Electric Co., Ltd., MiTAC Holdings Corporation, Lumentum Holdings Inc. and others, to achieve PCF calculation and CO2 emissions data exchange using actual data in accordance with global standards.Fujitsu, drawing from its experience and insights as a core member in the rule-making process around PCF calculation and product-level data exchange across value chains both in Japan and internationally, is well-versed in the progress of each supplier's decarbonization efforts and industry-specific challenges.As part of this initiative, in addition to the globally standardized product-based PCF calculation methodology (3) and product-level data on CO2 emissions exchange, Fujitsu successfully implemented the world's first offering that enables organization-based PCF calculation methodology (4) and data exchange, which are more prevalent among suppliers, using actual data for social implementation.Furthermore, to address suppliers' concerns about possible leakage of confidential information (i.e., product design details) in promoting CO2 emissions data exchange between companies Fujitsu’s ESG Management Platform ensures transparency and reliability through a highly confidential decentralized data management model that limits access rights to PCF calculations and connects only PCF data via an API (Application Programming Interface).By linking the CO2 emissions of suppliers from upstream in the supply chain, the platform enables the visualization of the effects of CO2 emission reduction measures, such as the introduction of renewable energy implemented by suppliers.This makes the CO2 emission reduction efforts across the entire supply chain visible as value, which can then be reflected in CO2 emission reduction scenarios for decarbonization and simulations of the effectiveness of measures.Fujitsu will continue to support a wide range of clients, including manufacturers, by combining and analyzing non-financial data such as CO2 reduction efforts with financial data including sales data, and contribute to the realization of a decarbonized supply chain.Fujitsu will report on this initiative at the ICT×Green Seminar hosted by the Japanese Ministry of Internal Affairs and Communications at the Japan Pavilion during COP29 on November 16, 2024, and will also discuss the advanced initiatives of Japanese companies.Takeshi Ogamino, Corporate Vice President, General Manager, FITEL Products Division, Communications Solutions Division, Furukawa Electric Co., Ltd., comments:“I am truly delighted that the collaboration with Fujitsu on carbon footprint data integration has been successful. Fujitsu has provided us with guidance on data integration and solutions compliant with PACT, enabling us to integrate the carbon footprint of our communication semiconductor laser products and advance new initiatives to reduce GHG emissions across the entire value chain. Looking ahead, we will continue to contribute to further GHG emission reductions, aiming for carbon neutrality by 2050 and societal transformation, to realize a sustainable future.”Xavier Denoly, Senior Vice President, Sustainable Development, Schneider Electric, comments:“Schneider Electric is working to reach net zero CO2 emissions throughout its entire supply chain, and we are pleased to work in collaboration with Fujitsu on these challenges. To help solve issues, it is important to use global standards to facilitate cooperation across the value chain.”PCF calculation and data exchange leveraging Fujitsu‘s ESG Management PlatformThe PCF calculation method on the ESG Management Platform used for this initiative leverages the “PACT Methodology” (5) and conformant to Japan’s “Green x Digital Consortium CO2 Visualization Framework (Edition 2.0.1)” powered by Japan Electronics and Information Technology Industries Association (JEITA) (6). In terms of data integration on the ESG Management Platform, it has passed interoperability tests conducted by PACT with solutions from the Digital Sustainability Cloud (DSC) of Institute for Information Industry, III in Taiwan (7) and Evalue8 Sustainability in Australia (8), and has been certified as a PACT-conformant solution in conformance to the tech specification of the "Pathfinder Framework (Version 2.2.0)" (9) as the globally standard. Utilizing the PACT-conformant solution enables data exchange on CO2 emissions between companies across countries. Moving forward, it will be possible to smoothly implement data exchange with companies based in Europe, the United States, Taiwan, and Australia. Furthermore, this data exchange also conformant to the "Green x Digital Consortium Technical Specifications for Data Exchange (Version 2.0)"..Figure: Using the ESG Management Platform Offering from Fujitsu UvanceFuture PlansFujitsu will continue to actively engage in visualizing and implementing measures to reduce CO2 emissions in the supply chain by leveraging technologies such as data and AI, while also providing the know-how gained through practice to customers and society via its ESG Management Platform.As part of Fujitsu Uvance, Fujitsu's business model to solve societal issues, Fujitsu will contribute to the realization of a sustainable supply chain and global carbon neutrality.Fujitsu will also continue to cooperate with industry organizations including the WBCSD (10) to support efforts towards rule-making aimed at achieving net-zero CO2 emissions across the entire value chain, responding to updates in global standard specifications, and strengthening supplier engagement.(1) Net zero CO2 emissions:Balancing residual emissions with the same amount of neutralization. Fujitsu aims to reduce CO2 emissions by more than 90% from the base year of 2020 by the target year of 2040. The remaining emissions of 10% or less are planned to be removed and stored through technologies that directly capture CO2 emissions from the atmosphere and absorption through afforestation.(2) 12 global suppliers:Accton Technology Corporation: Headquartered in Hsinchu, Taiwan, Chairperson Kuo-Hsiu HuangKAGA FEI Co., Ltd.: Headquartered in Kanagawa Prefecture, Japan, Representative Director, President Takeshi TsukamotoNEXTY Electronics Corporation: Headquartered in Tokyo, Japan, Representative Director, President Yasuhiro KakiharaSchneider Electric: Headquartered in Rueil-Malmaison, France, Chief Executive Officer Olivier BlumHakuto Co., Ltd.: Headquartered in Tokyo, Japan, Representative Director, President and Chief Executive Officer Tamaki MiyashitaFurukawa Electric Co., Ltd.: Headquartered in Tokyo, Japan, President (Representative) Hideya MoridairaMiTAC Holdings Corporation: Headquartered in Taoyuan, Taiwan, Chairman Matthew MiauLumentum Holdings Inc.: Headquartered in California, United States, President and Chief Executive Officer Alan Lowe(3) Product-based PCF calculation methodology:Method of calculating PCF based on the life cycle inventory analysis of greenhouse gases for each product. Requirement in PACT under global standards.(4) Organization-based PCF calculation methodology:Method of allocating Scope 1, 2, and 3 data as an organization by delivery amount, etc., for each delivery destination. Recognized as a transitional calculation method in the "Green x Digital Consortium CO2 Visualization Framework (Edition 2.0.1)" powered by JEITA(Japan Electronics and Information Technology Industries Association) and is proposed as an extension of PACT.(5) PACT Methodology:Guidance indicating the methodology for calculating and exchanging CO2 emission data.Previously, it was called Pathfinder Framework. The PACT Methodology builds on existing frameworks and standards to provide guidance on accounting, verification, and exchange of cradle-to-gate PCFs with the aim of creating more accurate, granular, and comparable emissions data. The PACT Methodology can be accessed here, with v 3.0 of the methodology and tech specs due to be released in Q1 2025.(6) Green x Digital Consortium CO2 Visualization Framework (Edition 2.0.1):Product carbon footprint calculation rules compiled by the Green x Digital Consortium Visualization WG.(7) Institute for Information Industry, III:Headquartered in Taipei City, Taiwan, DTRI Senior Deputy Director General Hubert Wang(8) Evalue8 Sustainability:Headquartered in Canberra, Australia(9) The tech specification of the Pathfinder Framework (Version 2.2.0):International technical specification for confidential and secure data exchange of emission data between companies based on solution interoperability. Solutions conformance to this technical specification are listed as PACT-conformant solutions in the PACT online catalog.(10) World Business Council for Sustainable Development (WBCSD):Organization led by CEOs of approximately 230 global companies aiming to achieve a sustainable society through business activities, with Fujitsu serving as a board member.About FujitsuFujitsu’s purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers in over 100 countries, our 124,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: Computing, Networks, AI, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.7 trillion yen (US$26 billion) for the fiscal year ended March 31, 2024 and remains the top digital services company in Japan by market share. Find out more: www.fujitsu.com.Press Contacts:Fujitsu LimitedPublic and Investor Relations DivisionInquiries Copyright 2024 JCN Newswire via SeaPRwire.com.

TOKYO, Nov 15, 2024 - (JCN Newswire via SeaPRwire.com) - TANAKA Kikinzoku Kogyo K.K. (Head office: Chuo-ku, Tokyo; Representative Director & CEO: Koichiro Tanaka), which develops industrial precious metal products as one of the core companies of TANAKA Precious Metals, announced that it has succeeded in developing the world’s first bulk2 platinum with controlled crystal grain3 size in the nano scale.The average grain size of a typical bulk metal is about 10 μm at the smallest. In this new technology, the average crystal grain size can be controlled in the nano scale. As a result, the developed pure platinum, with 99.9% or higher purity, has 10 times the hardness and 4 times the strength of typical platinum materials.It is known that the properties of metals, including precious metals, are enhanced by grain refinement. In recent years, steel and nonferrous metals with nano-sized crystal grains have been produced by deformation processing to apply extreme levels of plastic deformation5 and recrystallize their structures. While deformation processing temporarily hardens6 metal materials, when highly pure precious metal materials undergo the same process, the arrangement of atoms that form their crystalline structure changes and new crystal grains are nucleated and grown over periods of a few hours to a few days. As a result, the hardness of the material noticeably decreases (softens), and it has been very difficult to refine the crystal grains through deformation processing.TANAKA Kikinzoku Kogyo has succeeded in manufacturing bulk platinum with controlled crystal grain size in the nano scale by optimizing the manufacturing process. The hardness and strength of the platinum materials manufactured by this technology are much higher than those of typical platinum materials. The developed platinum has a high density of small-angle grain boundaries, large-angle grain boundaries, dislocations, and other lattice defects within the material. Therefore, the developed platinum has properties that are clearly different from the properties of commonly known platinum materials, even without additive elements or alloying. As a new material with high purity and high functionality, it is expected to be applied to a wide field of industries, including the electronics and aerospace industries.Material Development of Nanostructured BulkMany metal materials are polycrystalline, consisting of small crystal grains. It is considered that their properties can be improved by refinement of the crystal grains. The finer the grains, the higher the proportion of grain boundaries or lattice defects, such as dislocations, in the overall material. In materials with nanoscale grain, the ratio of lattice defects is incomparably higher than in commonly known materials, of which the physical properties and characteristics are usually discussed. As a result, unique physical properties and characteristics that are dramatically different from conventional materials are obtained.1 World’s first: As of October 30, 2024, and based on internal research (according to a survey of patents and papers on bulk platinum materials)2 Bulky, bulk: Bulky refers to the state of material where clumps of atoms within the material, not on the surface, are connected three-dimensionally. Solid matter with a bulky structure is called bulk.3 Crystal grains, crystal grain size: Metals have a structure with a regular arrangement of atoms. Crystal grains refer to individual areas of this structure where the orientation of the atomic arrangement is different from neighboring areas, and crystal grain size refers to the diameter of the grains.4 Electron backscatter diffraction (EBSD): A method of investigating information on material crystals (crystal system, grain size, orientation, etc.) by analyzing the backscatter diffraction from the surface of a material with a crystalline structure when irradiated with an electron beam5 Plastic deformation: The amount of deformation that remains in a material, without it returning to its original state, after applying an external force to the material to deform it and then removing that external force6 Work-hardened: The phenomenon of a metal being hardened by applying stress to the metal to accumulate plastic deformation7 Royal Pure Platinum: An original material manufactured by TANAKA Kikinzoku Kogyo, with higher hardness and strength than normal platinum materials while maintaining a purity of 99.9%About TANAKA Precious MetalsSince its foundation in 1885, TANAKA Precious Metals has built a portfolio of products to support a diversified range of business uses focused on precious metals. TANAKA is a leader in Japan regarding the volume of precious metals it handles. Over many years, TANAKA has manufactured and sold precious metal products for industry and provided precious metals in such forms as jewelry and assets. As precious metals specialists, all Group companies in Japan and worldwide collaborate on manufacturing, sales, and technology development to offer a full range of products and services. With 5,355 employees, the group’s consolidated net sales for the fiscal year ending December 2023, was 611.1 billion yen.Global industrial business websitehttps://tanaka-preciousmetals.com/en/Product inquiriesTANAKA Kikinzoku Kogyo K.K.https://tanaka-preciousmetals.com/en/inquiries-on-industrial-products/Press inquiriesTANAKA Holdings Co., Ltd.https://tanaka-preciousmetals.com/en/inquiries-for-media/Press release: http://www.acnnewswire.com/docs/files/20241114_EN.pdf  Copyright 2024 JCN Newswire via SeaPRwire.com.

Chigasaki, Japan, Nov 14, 2024 - (JCN Newswire via SeaPRwire.com) - ULVAC, Inc. (HQ: Chigasaki, Kanagawa) has announced a new oil rotary vacuum pump Gv135 optimized for the analytical equipment industry. This product addresses the industry's need for quiet operation in analytical environments and is designed to improve operational productivity through advanced noise reduction and robust oil leakage and backflow prevention measures.Quiet Operation in Sensitive EnvironmentsVacuum pumps are increasingly used in quiet environments such as research labs and offices, with analytical equipment manufacturers emphasizing the need for quieter pumps integrated within their systems. In response, ULVAC redesigned the pump structure to achieve significant noise reduction, reaching 46 dB - a substantial improvement over previous models. This reduces operational noise and offers a more comfortable work environment.Comparison of noise levels with previous models: https://youtu.be/W9fjMhRNZVI50Hz: Previous model 50 dB, Gv135 46 dB / 60Hz: Previous model 55 dB, Gv135 48 dBComplete Prevention of Oil Leakage from the Pump Gv135 incorporates a non-contact magnetic coupling in the shaft that transmits motor power to the pump chamber, eliminating oil leaks from this component. Oil rotary vacuum pumps used contact-type mechanical seals, which risk oil leakage as they degrade with motor rotation.Gv135 addresses this issue by removing the risk of oil leaks caused by seal degradation, thereby reducing the need for floor cleaning and oil handling, allowing users to focus on their primary tasks.Reduced Risk of Oil Backflow into EquipmentAdditionally, Gv135 features a dual-block structure with automatic valves at the intake and within the pump that close when the power is turned off, ensuring complete backflow prevention. This reduces the risk of oil contamination in equipment piping and sensors, supporting both equipment protection and reduced maintenance costs.Looking ahead, the company plans to release a series model of an oil rotary vacuum pump with a capacity of 200 L/min next year to further meet customer requirements. The ULVAC Group remains committed to contributing to the advancement of industry and science through the comprehensive utilization of vacuum and related technologies.Specifications of Gv135Exhaust speed 50Hz135 L/minExhaust speed 60Hz162 L/minUltimate pressure5.0×10E-1 PaNoise level 50Hz/60Hz46 / 48 dB (A)Weight28 kgDimensions166(W)×470(L)×241.5(H)Power supply voltageAC1φ 100-120 / 200-240V About ULVAC, Inc. Since its founding in 1952, ULVAC, Inc. has been a comprehensive vacuum equipment manufacturer, providing manufacturing equipment, components, analytical instruments, materials, and services based on its core technology - vacuum technology. Working with customers across a wide range of industries, including semiconductors, electronic components, displays, automotive, and pharmaceuticals, ULVAC is committed to driving cutting-edge innovation and creating new value. For the fiscal year ending June 2024, the ULVAC Group recorded consolidated sales of 261.1 billion yen and has approximately 6,200 employees. For more information, please visit our official website at https://www.ulvac.co.jp/en/For more information:ULVAC, Inc. Components Business HQTEL: +81-467-89-2261Inquiry Form: https://showcase.ulvac.co.jp/en/contact/showcase-pump.html Copyright 2024 JCN Newswire via SeaPRwire.com.

TOKYO, Nov 13, 2024 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Heavy Industries, Ltd. (MHI) published its integrated report, MHI REPORT 2024, on the 13th. The contents of the report have been revamped and enhanced with the launch of the 2024 Medium-Term Business Plan (MTBP), which was announced in May 2024.MHI REPORT 2024In a message from the President and CEO at the beginning, CEO Seiji Izumisawa discusses the Group's core value and raison d'etre, "leveraging our manufacturing expertise to address changing societal issues, we will help realize a safe, secure, and sustainable society," sharing personal anecdotes. Next, in a message from the CFO, CFO Hisato Kozawa provides an outline of financial strategies and targets, as well as the new dividend policy under the 2024 MTBP.Two feature articles are included. The first feature covers the 2024 MTBP. In addition to explains the contents of the 2024 MTBP, centering on the strategy to strengthen portfolio management, the feature explores the position and aims of the 2024 MTBP through a conversation between CSO Masayuki Suematsu, who is responsible for formulating the business plan, and Masatoshi Fujiwara, Professor at Hitotsubashi University's Graduate School of Business Administration. The second feature provides an update on last year's coverage of MISSION NET ZERO, the MHI Group's plan to achieve net zero CO2 emissions by 2040. Details include the basic strategy to achieve net zero emissions and progress on this strategy, decarbonization technology that is contributing to the realization of a carbon-neutral society, and initiatives by GX Solutions, a new business domain, which was established in April 2024. The feature also explains the initiatives at Mihara Machinery Works, as a pilot plant in an advanced project to realize Carbon Neutrality. The plant has been renamed Carbon Neutral Transition Hub Mihara, where the Group will actively consolidate and implement decarbonization solutions and utilize it as a hub for ongoing initiatives for co-creation with many stakeholders. There are pages providing an overview of each of the Group's businesses and explaining the business environment, key strategies in the medium to long term, and major projects of the Group's four reporting segments: Energy Systems, Plants & Infrastructure Systems, Logistics, Thermal & Drive Systems, and Aircraft, Defense & Space.The latter half of the report explains elements such as the basic principles and systems of the corporate governance supporting sustainable growth of the Group, as well as sustainability initiatives. In messages from outside directors, two of the Company's outside directors, Mitsuhiro Furusawa and Masako Ii, discuss topics such as the Company's governance and their views on the 2024 MTBP. There is also content on sustainability, covering policies and implementation systems of sustainability management, human rights and biodiversity initiatives, Company-wide SDG-linked Material Issues and metrics for monitoring progress (KPIs), and the Company's response to risks and opportunities caused by climate change (disclosures in line with the TCFD* recommendations). With regards to human capital, an article titled MHI Group's HR Strategy: Launching the Future provides details on HR strategies to realize management strategy of MHI Group.Going forward, MHI Group will continue issuing integrated reports outlining how the Group is contributing to resolving societal issues as it simultaneously pursues sustainable business growth and ongoing enhancement of its corporate value, presented with a careful balance of financial and non-financial information and in a format easily digestible by shareholders, investors, and all other stakeholders.*The TCFD (Task Force on Climate-related Financial Disclosures) is a framework established at the request of the Financial Stability Board, comprising central banks and financial authorities around the world along with international bodies and calling for disclosures of initiatives and information related to climate change. Recommendations for disclosures cover four categories: Governance, Strategy, Risk Management, and Metrics and Targets.Integrated Report: MHI REPORT 2024About MHI GroupMitsubishi Heavy Industries (MHI) Group is one of the world’s leading industrial groups, spanning energy, smart infrastructure, industrial machinery, aerospace and defense. MHI Group combines cutting-edge technology with deep experience to deliver innovative, integrated solutions that help to realize a carbon neutral world, improve the quality of life and ensure a safer world. For more information, please visit www.mhi.com or follow our insights and stories on spectra.mhi.com. Copyright 2024 JCN Newswire via SeaPRwire.com.

Tokyo and Kawasaki, Japan, Nov 13, 2024 - (JCN Newswire via SeaPRwire.com) - SoftBank Corp. (1) ("SoftBank") and Fujitsu Limited (2) ("Fujitsu") signed a memorandum of understanding on October 25, 2024, to strengthen their partnership toward realizing the commercialization of “AI-RAN” (3), a new architecture that integrates AI and RAN (Radio Access Network), targeted for 2026 and beyond. In accordance with this agreement, the two companies will commence joint research and development of software to maximize RAN performance and enhance communication quality through AI on the "AI-RAN", and in addition, will establish a verification lab at Fujitsu's site in Dallas, Texas, USA.SoftBank and Fujitsu ("the companies") are already collaborating on an outdoor proof-of-concept for AI-RAN conducted by SoftBank that commenced in October 2024. Fujitsu is providing vRAN (virtual Radio Access Network) software and Radio Units (RUs) for this proof-of-concept, which support Layer 1 software developed based on the “NVIDIA AI Aerial platform” that runs on the NVIDIA GH200 Grace Hopper Superchip, and the companies have confirmed their ability to manage high-quality simultaneous communication for up to 20 cells per server.To accelerate the realization of AI-RAN commercialization, the companies will jointly commence the following initiatives:1. Establish a Verification Lab to Accelerate AI-RAN CommercializationA verification lab will be jointly established in Dallas, Texas, USA, where Fujitsu is located. The lab will serve as a site for validating hardware, software, and applications that constitute AI-RAN, as well as a venue for new business creation. With this lab, the companies will not only conduct technical verification but also promote the understanding and ecosystem of AI-RAN, aiming to advance the practical application of AI-RAN in the global market.2. Research and Development of vRAN Software to Promote "AI for RAN" (4)Joint research and development will be carried out to develop software that leverages AI to maximize RAN performance. Utilizing the insights gained from the outdoor proof-of-concept, efforts will focus on applying AI to enhance communication performance in real-world environments, to advance the commercialization of AI-RAN.The companies aim not only to significantly improve investment efficiency on mobile infrastructure by enhancing and refining RAN features and performance through AI, but also drive new services and bring about various innovations in society and industry by improving communication quality for users even during times of mobility and congestion, and enable real-time response and analysis.Comments from Key ExecutivesHideyuki Tsukuda, Executive Vice President & CTO, SoftBank Corp.:"We are excited to take a step forward toward the commercialization of AI-RAN through this strengthened partnership. We anticipate further advancements in RAN efficiency and sophistication through AI, which will accelerate the practical application of AI-RAN."Shingo Mizuno, Corporate Executive Officer EVP, Vice Head of System Platform (in charge of Network Business), Fujitsu Limited comments:"Fujitsu has been engaged in the development of high-performance vRAN software utilizing GPUs for a number of years. By strengthening our partnership with SoftBank, Fujitsu aims to accelerate the creation of new business through combining the technologies and practical knowledge of both companies at a higher level, and provide increased value to customers and society."(1) SoftBank Corp. :Headquartered in Minato-ku, Tokyo; President & CEO: Junichi Miyakawa(2) Fujitsu Limited :Headquartered in Kawasaki City, Kanagawa Prefecture; Representative Director and President: Takahito Tokita(3) AI-RAN :A technology to achieve next-generation mobile networks through the fusion of AI and RAN.(4) AI for RAN :A concept promoted by SoftBank to maximize RAN performance through the application of AI/ML in AI-RAN.*SoftBank, the SoftBank name, and logo are registered trademarks or trademarks of SoftBank Group Corp. in Japan and other countries.*Other company, product, and service names in this press release are registered trademarks or trademarks of the respective companies.About FujitsuFujitsu’s purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers in over 100 countries, our 124,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: Computing, Networks, AI, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.7 trillion yen (US$26 billion) for the fiscal year ended March 31, 2024 and remains the top digital services company in Japan by market share. Find out more: www.fujitsu.com.Press ContactsFujitsu LimitedPublic and Investor Relations DivisionInquiries Copyright 2024 JCN Newswire via SeaPRwire.com.

PALO ALTO, CA, Nov 13, 2024 - (JCN Newswire via SeaPRwire.com) - NEC X, the Silicon Valley venture studio backed by NEC’s portfolio of advanced technologies and global businesses, today announced a new investment in General Prognostics Inc. (GPx), a fast-growing MedTech startup revolutionizing chronic disease monitoring and management.The investment coincides with GPx joining the Elev X! Boost program, an individually tailored venture program for ambitious startups that are ready to scale. The program offers a unique blend of capital, strategic partnerships, and integrations with NEC X’s expansive tech ecosystem to propel startups to global success.Through Elev X! Boost, GPx will refine the accuracy of its debut product, CardioID, the world’s first implant and needle-free remote blood monitoring solution for heart failure patients, while growing revenue, expanding into new markets and securing additional funding. The system, developed by GPx, extracts biomarkers from wearable devices, such as heart rate, heart rate variability, step count, and voice data, and employs machine learning to develop predictive models that surpass the accuracy of traditional implant-based monitoring solutions."GPx’s innovative approach to heart monitoring and chronic disease management is a perfect fit for the NEC Group’s vision of leveraging advanced technology to improve quality of life," said Shintaro Matsumoto, President and CEO of NEC X. "By joining forces with GPx, we aim to enhance their predictive algorithms and capabilities. Together, we can transform the healthcare industry."GPx aims to improve the lives of individuals with chronic diseases by providing personalized, predictive monitoring solutions. Conventional heart failure monitoring typically relies on invasive implants, limiting its use to patients with severe conditions. CardioID addresses this gap by offering non-invasive, real-time monitoring without the need for surgery or frequent blood tests, significantly expanding access to continuous care for the majority of heart failure patients who are unable to receive implant-based monitoring."NEC X’s investment and strategic partnership are invaluable as we work to expand our mission of providing personalized healthcare solutions to millions of patients," said Sean Matsuoka, Co-Founder of GPx. "This collaboration will not only help us improve the performance of our technology, but also accelerate our growth and ability to help patients with chronic diseases worldwide."GPx’s leadership team, composed of graduates from MIT and Harvard, offers deep expertise across engineering, legal, product management, and sales in healthcare and medical devices. Its co-founders Sean Matsuoka and Javier Echenique have held leadership roles at Caresyntax, M3, McKinsey & Company, Sony Corporation, Jana Care, Medtronic, and Volcano. Additionally, the startup’s founding advisor, Sidhant Jena co-founded and served as CEO of new windowJana Care and held R&D leadership roles at Medtronic.The investment in GPx is part of NEC X’s broader strategy to support healthcare innovation. By fostering partnerships with startups like GPx, NEC X aims to address critical challenges in healthcare, such as improving access to monitoring for chronic disease patients and reducing the burden on healthcare systems. The investment will support GPx’s growth and development as they prepare to scale their operations and bring CardioID to market.About General Prognostics Inc.General Prognostics (GPx) is revolutionizing remote chronic disease management with the world's first bloodless blood tests. Headquartered in Boston, MA, GPx is dedicated to transforming the standard of care of chronic diseases and enabling patients to better understand their condition, much like the continuous glucose monitor has transformed diabetes care.For more information about GPx and their innovative healthcare solutions, visit https://www.gpx.ai. About NEC XNEC X is an innovation powerhouse and curator of disruptive startups backed by the global technology leadership of NEC. Leveraging 125 years of IT and network technologies expertise, NEC X’s startup-focused approach transforms visionary ideas into commercial successes that revolutionize how we work and live. Since its inception in 2018, NEC X has helped launch and grow more than 100 startups.Their Silicon Valley programs – Elev X! Ignite and Elev X! Boost – equip early-stage startup founders with the tools to fast-track their tech development and adoption. Elev X! fuels startup success from inception to launch, connecting innovators with NEC’s 45,000 patents; global network of partners, mentors and advisors; reach into 55+ international markets; and $8 billion R&D ecosystem.For more information, visit https://nec-x.com and new windowhttps://www.elev-x.com. About NEC CorporationNEC Corporation has established itself as a leader in the integration of IT and network technologies while promoting the brand statement of “Orchestrating a brighter world.” NEC enables businesses and communities to adapt to rapid changes taking place in both society and the market as it provides for the social values of safety, security, fairness and efficiency to promote a more sustainable world where everyone has the chance to reach their full potential. For more information, visit NEC at https://www.nec.com. Copyright 2024 JCN Newswire via SeaPRwire.com.

TOKYO, Nov 13, 2024 - (JCN Newswire via SeaPRwire.com) - NEC Corporation (NEC; TSE: 6701) has received an order for a next-generation supercomputer system from Japan’s National Institutes for Quantum Science and Technology (QST), under the National Research and Development Agency, and the National Institute for Fusion Science (NIFS), part of the National Institutes of Natural Sciences under the Inter-University Research Institute Corporation. The new supercomputer system is scheduled to be operational from July 2025.The next-generation supercomputer system will feature multi-architecture with the latest CPUs and GPUs and will consist of large storage capacity and a high-speed network. This system is expected to be used for various research and development in the field of fusion science research. Specifically, the system will be used for precise prediction of experiments and creation of operation scenarios in the ITER project, which is being promoted as an international project, and the Satellite Tokamak (JT-60SA) project, which is being promoted as a Broader Approach activity, and for design of DEMO reactors. The DEMO project promotes large-scale numerical calculations for DEMO design and R&D to accelerate the realization of a DEMO reactor that contributes to carbon neutrality. In addition, NIFS will conduct numerical simulation research using the supercomputer for multi-scale and multi-physics systems, including fusion plasmas, to broadly accelerate research on the science and applications of fusion plasmas, and as an Inter-University Research Institute, will provide universities and research institutes nationwide with opportunities for collaborative research using the state-of-the-art supercomputer.The new system consists mainly of 360 NEC LX 204Bin-3s (with a total of 720 Intel Xeon 6900Ps) and 70 NEC LX 401Bax-3GAs (with a total of 280 AMD Instinct MI300As), with total theoretical performance of 40.4 petaflops of computing power. Theoretical computing performance will be approximately 2.7 times higher than the combined performance of the two supercomputers installed separately at QST and NIFS. The NEC LX 204Bin-3 is equipped with MRDIMMs, which have high performance in HPC programs.The supercomputer system consists mainly of the "LX series," which was developed by combining the high-density packaging technology and high-efficiency cooling technology that NEC has developed over many years in the development of supercomputers. The Intel "CPU Xeon6900P," "MRDIMM," and AMD’s “Instinct MI300A" GPUs installed in these server groups are the first introduction of its kind in Japan. In addition, the network environment uses "InfiniBand" with the NVIDIA “QM9700," "Altair PBS Professional" software, and a scheduler optimized for AMD’s Instinct MI300A. In addition, as a storage environment, a DDN “ES400NVX2" will be deployed with a total capacity of 42.2 petabytes with a Lustre parallel file system "EXAScaler." NEC will integrate these components along with software optimization.NEC will continue to contribute to the development of cutting-edge technologies by promoting the development of next-generation high-performance servers as a foundation for utilization in industrial applications and AI/Big Data domains, as well as the conventional application areas of supercomputers. NEC will also support research activities in the academic domain by providing academic research information infrastructure with HPC solutions at its core as one of its BluStellar offerings.“Intel is proud to partner with NEC to power a system at the National Institutes for Quantum Science and Technology and National Institute for Fusion Science. By integrating the Intel Xeon 6900P Series, the first server CPU to support MRDIMMs, and the first in Japan, we’re delivering a leap in memory performance and bandwidth, an ideal choice for complex calculations and simulations required in fusion research.”– Ogi Brkic, Vice President & General Manager, Go-To-Market Builders & Technology Acceleration Office, Sales & Marketing Group, Intel“We are very pleased that NEC has chosen to partner with AMD to power the next generation supercomputers ordered by both the National Institutes for Quantum Science and Technology and the National Institute for Fusion Science in Japan. We appreciate that NEC has selected AMD’s Instinct MI300A and this choice is further proof that AMD’s MI300 Series GPUs offer a compelling supercomputer accelerator solution. We believe that AMD innovation, together with NEC's advanced technological capabilities, will continue to make a significant contribution to research conducted at the National Institutes for Quantum Science and Technology, and the National Institute for Fusion Science.”-Jon Robottom, Corporate Vice President, Representative Director & General Manager, AMD Japan“DDN is honored to continue to support cutting-edge fusion research at the National Institutes for Quantum Science and Technology and the National Institute for Fusion Science through our strong collaboration with NEC. The combination of DDN's high-performance storage solution and NEC's superior technology will provide stable performance and fast processing of large data sets to power complex simulations and advanced analytics in fusion science research. We are confident that through this collaboration, we will be able to accelerate innovative discoveries and technology development.”-Robert Triendl, SVP Sales, International, DataDirect Networks, Inc. (DDN)"With our specialized solutions, Giga Computing is proud to support the missions of both the National Institutes for Quantum Science and Technology and the National Institute for Fusion Science in advancing scientific discovery. For this cluster, our technology is incorporated into the NEC LX series servers with one of our models equipped with Intel Xeon 6900P series processors and MRDIMM technology, while the other uses the AMD Instinct MI300A GPU. This high-performance solution uses efficient liquid cooling to deliver remarkable processing speeds for nuclear fusion and complex plasma simulations. Consequently, it enables the institutes to achieve faster, more accurate results in the field of advanced nuclear fusion research.”-Freya Yu, Sales Director, Giga Computing“We are very pleased to collaborate with NEC in the selection of Altair PBS Professional for the next-generation supercomputer system at the National Institutes for Quantum Science and Technology and the National Institute for Fusion Science. We are confident that Altair PBS Professional is the industry's most advanced workload management and job scheduling software for HPC and high-throughput computing, and that it will contribute to improving the productivity of the supercomputer system and optimizing its utilization and efficiency. We will continue to work with NEC to help our customers solve their challenges.”-Eiichi Kazono, President and Representative Director, Altair Engineering, Inc.“We are very pleased to have been able to support the construction of a networking environment in partnership with NEC Corporation. The NVIDIA QM9700 is a networking switch that uses high-speed interconnect technology and is optimized for large-scale computing environments, especially for AI and academic research. It demonstrates its true value in data transfer for numerical analysis and simulations that require massive data processing. We are confident that this will further accelerate the research and development projects at the National Institutes for Quantum Science and Technology and the National Institute for Fusion Science and support the technological foundation for more innovative results. We will continue to strengthen our collaboration with NEC on networking products to accelerate the progress of our customers' research.”- Yukihiro Tsujii, General Manager, Solution Business Division, Ryoyo Electro Co.About NEC CorporationNEC Corporation has established itself as a leader in the integration of IT and network technologies while promoting the brand statement of “Orchestrating a brighter world.” NEC enables businesses and communities to adapt to rapid changes taking place in both society and the market as it provides for the social values of safety, security, fairness and efficiency to promote a more sustainable world where everyone has the chance to reach their full potential. For more information, visit NEC at https://www.nec.com. Copyright 2024 JCN Newswire via SeaPRwire.com.